These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 36198829)

  • 21. Comparing the effectiveness of continuous subcutaneous insulin infusion with multiple daily insulin injection for patients with type 1 diabetes mellitus evaluated by retrospective continuous glucose monitoring: A real-world data analysis.
    Keyu G; Jiaqi L; Liyin Z; Jianan Y; Li F; Zhiyi D; Qin Z; Xia L; Lin Y; Zhiguang Z
    Front Public Health; 2022; 10():990281. PubMed ID: 36091534
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Advances in Continuous Glucose Monitoring and Integrated Devices for Management of Diabetes with Insulin-Based Therapy: Improvement in Glycemic Control.
    Yoo JH; Kim JH
    Diabetes Metab J; 2023 Jan; 47(1):27-41. PubMed ID: 36635028
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diabetes Technology-Continuous Subcutaneous Insulin Infusion Therapy and Continuous Glucose Monitoring in Adults: An Endocrine Society Clinical Practice Guideline.
    Peters AL; Ahmann AJ; Battelino T; Evert A; Hirsch IB; Murad MH; Winter WE; Wolpert H
    J Clin Endocrinol Metab; 2016 Nov; 101(11):3922-3937. PubMed ID: 27588440
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Short-term intensive insulin therapy could be the preferred option for new onset Type 2 diabetes mellitus patients with HbA1cā€‰>ā€‰9.
    Weng J
    J Diabetes; 2017 Oct; 9(10):890-893. PubMed ID: 28661564
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Review of Continuous Glucose Monitoring Data Interpretation in the Age of Automated Insulin Delivery.
    Ekhlaspour L; Tabatabai I; Buckingham B
    J Diabetes Sci Technol; 2019 Jul; 13(4):645-663. PubMed ID: 31130007
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Successful treatment of young infants presenting neonatal diabetes mellitus with continuous subcutaneous insulin infusion before genetic diagnosis.
    Rabbone I; Barbetti F; Marigliano M; Bonfanti R; Piccinno E; Ortolani F; Ignaccolo G; Maffeis C; Confetto S; Cerutti F; Zanfardino A; Iafusco D
    Acta Diabetol; 2016 Aug; 53(4):559-65. PubMed ID: 26831749
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Continuous Glucose Monitors and Automated Insulin Dosing Systems in the Hospital Consensus Guideline.
    Galindo RJ; Umpierrez GE; Rushakoff RJ; Basu A; Lohnes S; Nichols JH; Spanakis EK; Espinoza J; Palermo NE; Awadjie DG; Bak L; Buckingham B; Cook CB; Freckmann G; Heinemann L; Hovorka R; Mathioudakis N; Newman T; O'Neal DN; Rickert M; Sacks DB; Seley JJ; Wallia A; Shang T; Zhang JY; Han J; Klonoff DC
    J Diabetes Sci Technol; 2020 Nov; 14(6):1035-1064. PubMed ID: 32985262
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Technology in the management of type 2 diabetes: Present status and future prospects.
    Daly A; Hovorka R
    Diabetes Obes Metab; 2021 Aug; 23(8):1722-1732. PubMed ID: 33950566
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Quo vadis diabetes technology?].
    Grunberger G
    Cas Lek Cesk; 2017; 156(6):298-302. PubMed ID: 29212333
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quo vadis diabetes technology?
    Grunberger G
    Cas Lek Cesk; 2017; 156(6):293-297. PubMed ID: 29212332
    [TBL] [Abstract][Full Text] [Related]  

  • 31. INTEGRATED INSULIN PUMP AND CONTINUOUS GLUCOSE MONITORING TECHNOLOGY IN DIABETES CARE TODAY: A PERSPECTIVE OF REAL-LIFE EXPERIENCE WITH THE MINIMED
    Aleppo G; Webb KM
    Endocr Pract; 2018 Jul; 24(7):684-692. PubMed ID: 30048171
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Utilisation, access and recommendations regarding technologies for people living with type 1 diabetes: consensus statement of the ADS/ADEA/APEG/ADIPS Working Group.
    Pease AJ; Andrikopoulos S; Abraham MB; Craig ME; Fenton B; Overland J; Price S; Simmons D; Ross GP
    Med J Aust; 2021 Nov; 215(10):473-478. PubMed ID: 34148253
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Health care organization and use of technological devices in people with diabetes in Italy: Results from a survey of the Working Group on Diabetes and Technology.
    Pitocco D; Laurenzi A; Tomaselli L; Assaloni R; Consoli A; Di Bartolo P; Guardasole V; Lombardo F; Maffeis C; Rossi A; Gesuita R; Di Molfetta S; Rigamonti A; Scaramuzza A; Irace C; Cherubini V;
    Nutr Metab Cardiovasc Dis; 2022 Oct; 32(10):2392-2398. PubMed ID: 35970683
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Continuous Glucose Monitoring Integration in Clinical Practice: A Stepped Guide to Data Review and Interpretation.
    Aleppo G; Webb K
    J Diabetes Sci Technol; 2019 Jul; 13(4):664-673. PubMed ID: 30453772
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of technology on glycaemic control in type 2 diabetes: A meta-analysis of randomized trials on continuous glucose monitoring and continuous subcutaneous insulin infusion.
    Dicembrini I; Mannucci E; Monami M; Pala L
    Diabetes Obes Metab; 2019 Dec; 21(12):2619-2625. PubMed ID: 31368658
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Insulin Therapy and Diabetic Pregnancy.
    Napoli A
    Am J Ther; 2020; 27(1):e91-e105. PubMed ID: 31688066
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [From insulin pump and continuous glucose monitoring to the artificial pancreas].
    Apablaza P; Soto N; Codner E
    Rev Med Chil; 2017 May; 145(5):630-640. PubMed ID: 28898340
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Continuous subcutaneous insulin infusion versus multiple daily injections in children and young people at diagnosis of type 1 diabetes: the SCIPI RCT.
    Blair J; McKay A; Ridyard C; Thornborough K; Bedson E; Peak M; Didi M; Annan F; Gregory JW; Hughes D; Gamble C
    Health Technol Assess; 2018 Aug; 22(42):1-112. PubMed ID: 30109847
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Continuous Glucose Monitoring: A Review of Recent Studies Demonstrating Improved Glycemic Outcomes.
    Rodbard D
    Diabetes Technol Ther; 2017 Jun; 19(S3):S25-S37. PubMed ID: 28585879
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.